Discover 1,112 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,112
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: New Haven CT, Stony Brook NY, Albany NY, New York NY,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Location: New Haven CT, The Bronx NY, Hackensack NJ, New York NY,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06881784
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New Haven CT, Providence RI, Mineola NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, Providence RI, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase 1, Phase 2, Recruiting
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
for
Deep Venous Thrombosis
Location: New Haven CT, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Yale University
Sex: All
Age: 0 - 17
Code: NCT04924322
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Unified Network for Integrated Fluid Collection at Yale
for
Molecular Residual Disease, Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07689864
Recruiting
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, Philadelphia PA, Baltimore MD, Fairfax VA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07205718
Phase 1, Phase 2, Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
for
Sarcoma,Soft Tissue
Location: New Haven CT, Philadelphia PA, Toronto, Durham NC,
Sponsor: Intensity Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06263231
Phase 3, Recruiting
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
for
Advanced Microsatellite Stable Colorectal Cancer
Location: North Haven CT, Boston MA, Charlottesville VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07527858
Phase 2, Recruiting
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Location: New Haven CT, Trumbull CT, Fairfax VA, Nashville TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07519655
Phase 1, Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
for
Pneumonia Childhood, Pneumonia, Lung Ultrasound,
Location: New Haven CT
Sponsor: Meyer Children's Hospital IRCCS
Sex: All
Age: 3 - 10
Code: NCT06921993
Recruiting
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: New Haven CT, Boston MA, New York NY, Hackensack NJ,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase 1, Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
for
Liposarcoma, Prostate Cancer, Advanced Breast Cancer,
Location: New Haven CT, Trumbull CT, Grand Rapids MI,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT04557449
Phase 1, Phase 2, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Charlottesville VA, Cleveland OH,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
for
Meningioma
Location: New Haven CT, New York NY, Durham NC, Indianapolis IN,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07533942
Phase 2, Recruiting
A Trial of Varenicline for E-cigarette Cessation
for
E-cigarette Use, Vaping, Nicotine Dependence
Location: New Haven CT, Charleston SC
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07040566
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: New Haven CT, Trumbull CT, Newton MA, Boston MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase 1, Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New Haven CT, Hackensack NJ, Toronto, Halifax,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06988488
Phase 1, Phase 2, Recruiting
Evaluation of a Mobile App Program for Coping With Cancer